最新の情報は下記 URL でご確認いただけます (外部サイトへ移動します) 。
https://ftp.ncbi.nlm.nih.gov/pub/clinvar/tab_delimited/archive/
表のタイトル行が青色の項目は、クリックすることでソートすることができます。
| Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
|---|---|---|---|---|---|---|---|---|---|---|
| (GRCh37) | ||||||||||
| single nucleotide variant | NM_000535.7(PMS2):c.2276-2A>C | PMS2 | Likely pathogenic | 7 | 6017390 | 6017390 | T | G | criteria provided, single submitter | - |
| Duplication | NM_000535.7(PMS2):c.269_270dup (p.Lys91fs) | PMS2 | Pathogenic/Likely pathogenic | 7 | 6043403 | 6043404 | T | TAG | criteria provided, multiple submitters, no conflicts | - |
| Duplication | NM_000179.3(MSH6):c.1513dup (p.Tyr505fs) | MSH6 | Likely pathogenic | 2 | 48026634 | 48026635 | G | GT | criteria provided, single submitter | - |
| single nucleotide variant | NM_000251.3(MSH2):c.1832T>A (p.Val611Glu) | MSH2 | Likely pathogenic | 2 | 47702236 | 47702236 | T | A | criteria provided, single submitter | - |
| single nucleotide variant | NM_000249.4(MLH1):c.1029C>G (p.Tyr343Ter) | MLH1 | Pathogenic/Likely pathogenic | 3 | 37061945 | 37061945 | C | G | criteria provided, multiple submitters, no conflicts | - |
| Indel | NM_000251.3(MSH2):c.1046_1047delinsGC (p.Pro349Arg) | MSH2 | Likely pathogenic | 2 | 47643538 | 47643539 | CT | GC | reviewed by expert panel | - |
| single nucleotide variant | NM_000251.3(MSH2):c.2635-2A>G | MSH2 | Likely pathogenic | 2 | 47709916 | 47709916 | A | G | reviewed by expert panel | - |
| single nucleotide variant | NM_000179.3(MSH6):c.1445G>C (p.Arg482Pro) | MSH6 | Likely pathogenic | 2 | 48026567 | 48026567 | G | C | reviewed by expert panel | - |
| single nucleotide variant | NM_000179.3(MSH6):c.2234T>A (p.Ile745Asn) | MSH6 | Likely pathogenic | 2 | 48027356 | 48027356 | T | A | reviewed by expert panel | - |
| single nucleotide variant | NM_000249.4(MLH1):c.114C>A (p.Asn38Lys) | MLH1 | Likely pathogenic | 3 | 37035152 | 37035152 | C | A | reviewed by expert panel | - |